MedPath
HSA Approval

AXCEL BETAMETHASONE CREAM 0.1% w/w

SIN10969P

AXCEL BETAMETHASONE CREAM 0.1% w/w

AXCEL BETAMETHASONE CREAM 0.1% w/w

June 5, 1999

KOTRA PHARMA MARKETING

KOTRA PHARMA MARKETING

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantKOTRA PHARMA MARKETING
Licence HolderKOTRA PHARMA MARKETING

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CREAM

TOPICAL

Medical Information

D07AC01

betamethasone

Manufacturer Information

KOTRA PHARMA MARKETING

KOTRA PHARMA (M) SDN BHD

Active Ingredients

BETAMETHASONE 17-VALERATE (MICRONISED) EQV BETAMETHASONE

0.1% w/w

Betamethasone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AXCEL BETAMETHASONE CREAM 0.1% w/w - HSA Approval | MedPath